Symbol="TSHA"
AssetType="Common Stock"
Name="Taysha Gene TherapiesÂ Inc"
Description="Taysha Gene Therapies, Inc., a gene therapy company, focuses on the development and commercialization of adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. The company is headquartered in Dallas, Texas."
CIK="1806310"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="7318 MORTON STREET, DALLAS, TX, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="48012000"
EBITDA="-87692000"
PERatio="None"
PEGRatio="None"
BookValue="-0.235"
DividendPerShare="0"
DividendYield="0"
EPS="-2.66"
RevenuePerShareTTM="0.144"
ProfitMargin="0"
OperatingMarginTTM="-12.34"
ReturnOnAssetsTTM="-0.415"
ReturnOnEquityTTM="-7.45"
RevenueTTM="7208000"
GrossProfitTTM="2502000"
DilutedEPSTTM="-2.66"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="5.13"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="13.3"
EVToRevenue="-"
EVToEBITDA="-1.135"
Beta="1.165"
num_52WeekHigh="4.63"
num_52WeekLow="0.5"
num_50DayMovingAverage="0.707"
num_200DayMovingAverage="1.233"
SharesOutstanding="64179000"
DividendDate="None"
ExDividendDate="None"
symbol="TSHA"
open="0.75"
high="0.75"
low="0.70"
price="0.74"
volume="121169.00"
latest_trading_day="2023-08-11"
previous_close="0.70"
change="0.04"
change_percent="5.1209%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="90"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="10"
Volume_recent_avg="325700"
Change_recent_avg="-0.01"
Delta_recent_avg="0.07"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="-1.07"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="10"
Aroon_momentum_negative="90"
image_negative_thumbnail_id_1="513"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0092.jpeg"
image_negative_thumbnail_id_2="129"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0047.jpeg"
image_neutral_thumbnail_id_1="525"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0074.jpeg"
image_neutral_thumbnail_id_2="528"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0071.jpeg"
image_positive_thumbnail_id_1="626"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0082.jpeg"
image_positive_thumbnail_id_2="616"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0092.jpeg"
image_professor_thumbnail_id_1="1194"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
image_professor_thumbnail_id_2="1167"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0001.jpeg"
